physiologic levels and it was accelerated, within certain limits, when the dose was increased. Essentially the same results were obtained when animals were implanted with pellets of estrogen, a method which provides a greater constancy of hormonal action, except that fibroadenomas were more prone to occur prior to the appearance of carcinoma. Injections were more likely to produce duct carcinoma, particularly if ovariectomized rats were used, while pellets frequently induced infiltrating lobular cancer.
In the course of studies during the past five years on the development of adenomas of the hypophysis in the rat numerous tumors of the mammary glands have been o'bserved. This led us to give the question of mammary carcinoma further attention and finally to assemble the data which had been collected during the earlier observations.
Procedures
The studies reported at this time include observations upon three groups of rats. The animals in Group I (127 rats) received daily injections of 50 micrograms of diethylstilbestrol for periods ranging from 70 to 600 days. In Group II (29 rats) treatment consisted of the implantation of one to four 10 mg.-pellets of diethylstilbestrol, with observations ranging from 60 to 420 days. The rats in Group III (53 animals) received three to six 10 mg.-pellets of estrone and were observed for 60 to 500 days. Treatment was begun in all groups at ages ranging from 60 to 80 days. Both males and females were included in these groups and none was gonadectomized. These rats were derived from the Long-Evans hooded strain, and over a period of 15 years no spontaneous mammary tumors, with the exception of 4 fibroadenomas, have been observed. One of these appeared in a female of a series of controls studied in parallel with this experiment. Routine laboratory care, including main-tenance on Rockland Rat Ration and occasional greens, was given these animals.
Body weights and observations were taken routinely and the general condition of the animals was noted. When tumors appeared, usually detected initially as small nodular lumps, they were recorded and cobserved for further growth. The animals observed for the shorter periods were sacrificed at the desired intervals. In the case of more prolonged observations (more than 150 days) complications frequently arose and necessitated termination of the individual experiment, either through death of the animal or because its weakened condition indicated that death was imminent. These complications included pyometra, adenomas of the hypophysis in both sexes, and, less frequently, disorders of the urinary organs and respiratory infections.
At autopsy all mammary glands were observed and if any neoplasia was detected the lymph nodes and lungs were examined. In addition to samples   218   INDUCTION OF MAMMARY CARCINOMA IN RATS of these all endocrine organs, representative portions of the reproductive tract and portions of the kidneys and liver were taken routinely for fixation and study. If autopsy revealed any unusual condition in other organs they were preserved. Fixation was carried out with either Bouin's fluid or Zenkerformol and various staining procedures were followed, of which Masson's trichrome method and hematoxylin and eosin were routine.
Results
Group I. In animals which received 50 micrograms of diethylstilbestrol daily mammary changes ranging from simple hyperplasia, cystic hyperplasia and hypertrophy, and fibrosis to metaplasia, early duct carcinoma, advanced duct carcinoma, adenocarcinoma, and carcinoma simplex were observed. The several conditions of the mammary glands depended in part upon the length of the experiments, but the nature of the treatment appeared to emphasize the likelihood of the development of duct carcinoma in animals which lived more than 400 days after the initiation of injections.
Since no marked pathological change appeared in the mammary glands earlier than the 300th day of treatment, the animals which died or were sacrificed prior to this time will be considered together. Included in this sub-group are 73 of the 127 rats. In these the earliest evident effects of treatment included the usual extension of the duct system, proliferation of terminal buds, and early establishment of a lobular pattern. This effect appeared earlier in females, 'but a sexual difference was not readily apparent with longer treatment After injections had continued for about 130 days the glands usually presented the appearance of small and large cysts filled with a coagulated or inspissated secretion. This condition frequently was attained earlier, but was present uniformly before the end of the fifth month of treatment. The cysts appeared in the terminal ducts and the acini and, as the products of secretion accumulated, distension of the larger ducts occurred. Concomitant with or closely following the development of cysts the periductal and periacinar connective tissue increased in amount and density (Fig. 1) . This fibrosis was progressive throughout the period of cyst formation and during the more advanced stages of neoplasia.
Of the 54 animals which lived more than 300 days 39 were males. The frequent occurrence of pyometra reduced the number of females that survived. continued treatment. However, no significant difference has been observed between males and females in the development of metaplastic and neoplastic changes in the breast 219 and no distinction will be made between the sexes in the following discussion.
Ten animals in which treatment continued for from 480 to 600 days showed no pathological change of the mammary glands beyond cystic disease and fibrosis. Seven of these animals were sacrificed or died because of hypophysial tumors, one succumbed to pneumonia, and two became so severely cachectic that they were sacrificed. Autopsy indicated that chronic glomerular nephritis was the probable cause of their decline.
Eleven animals that died or were sacrificed 'between the 300th and 500th days of treatment showed metaplasia of the mammary parenchyma (Fig. 1) . This was evident principally in the smaller ducts and usually was seen in glands which also contained cysts. In some instances one or more of the glands showed appreciable thickening of the ductal epithelium with small papillomatous growths while other glands in the same animals showed cysts only. It seems probable that metaplastic change is a forerunner of duct carcinoma, since it has been seen frequently in conjuncti6n with the latter condition. Geschickter and Byrnes have expressed the opinion that the appearance of carcinoma is delayed when cysts form, since these must degenerate and atrophy before cancer can develop. Although this idea is probably correct it should be noted that such change is, primarily at least, a purely local transformation, since cysts, metaplasia and carcinoma may be seen co-existing in the same gland and, indeed, in the same general area.
In general, it may be said that metaplastic change in the glands of our animals marked the period between 300 and 400 days. The parenchymatous metaplasia was accompanied uniformly by advancing fibrosis which we believe is a constant forerunner of carcinoma in these animals. This fibrosis frequently contributes to the development of a condition which has been regarded as fibroadenoma by Geschickter and Byrnes.
Twenty-eight animals which survived more than 300 days showed some form of mammary carcinoma in one or more glands. In 10 animals, ranging from 400 to 560 days, the tumor was diagnosed as early duct carcinoma (Fig. 2) . In many regions of the cancerous glands, and in glands not involved by cancer, metaplasia and cystic disease were present. Without exception the existence of a carcinoma was accompanied by further increases in the density and quantity of stroma. In two animals regional lymph nodes showed metastatic foci.
In 11 of the remaining animals treatment was continued until termination of the individual experiment (500 to 600 days). Each of these rats showed advanced carcinoma and in 5 instances the cancers were regarded as the cause of death. Six animals showed duct carcinoma only (Fig. 3) , 3 had adenocarcinoma (Fig. 4) , in one both duct and adenocarcinoma were present in different glands, and one showed a variety of pictures in the several glands, two glands with carcinoma of ducts and acini, one with carcinoma simplex (Fig.  5 ), and one with co-existing adenofibroma and adenocarcinoma. In this sub-group metastases to the regional lymph nodes (Fig. 6) were seen in the 4 cases of adenocarcinoma and in 3 of these the lungs also showed metastatic foci. Metastases to lymph nodes were seen in 3 of the animals with duct carcinoma (Fig. 7) . In the rat with multiple tumors one metastatic focus, apparently of the carcinoma simplex, was seen in a lymph node.
In 12 animals treatment was suspended at the end of 400 days. This was done to observe the occurrence of neoplasia in the absence of further estrogenic activity. Treatment was stopped at the 400th day, since the earliest cases of carcinoma appeared at about that time. Three of the animals showed very small palpable nodules which on biopsy proved to be early duct carcinoma. Most of the animals presented symptoms of hypiophysial tumor when treatment was discontinued. However, in each instance these symptoms disappeared and, as revealed at autopsy, the hypophysial tumors underwent involution. In the animals which were examined six or more months later the hypophyses had returned to a size only slightly above normal.
Four animals were sacrificed at from 60 to 75 days after treatment was suspended. 
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The fourth rat showed cysts and metaplasia in all glands except one inguinal gland which had grown very rapidly during the course of three weeks and which upon section presented the picture of carcinoma simplex.
Four animals died or were sacrificed 1 70 to 185 days after cessation of treatment. Three of these showed duct carcinoma, with metastases to regional lymph nodes in one instance. The fourth animal showed no mammary pathological changes beyond a few persistent cysts and a minor degree of metaplasia.
Four animals died or were sacrificed from 240 to 270 days after treatment had been suspended. This group included the 3 animals which had shown small nodular growth. In each of the 4 cases duct carcinoma was present in several glands. Two animals showed metastatic foci in the regional lymph nodes and in the remaining 2 both lungs and lymph nodes contained metastases.
The results in the animals included in Group I are summarized in table 1. Group II. The animals in this group received from one to four 10 mg.-pellets of diethylstilbestrol implanted subcutaneously. In each rat the pellets were implanted singly at intervals of 3 to 4 months. The general trend of effects was similar to that seen in the animals of Group I where stilbestrol in oil had been administered by injection, except that the entire process was accelerated. Thus, the earliest instances of carcinoma occurred in this group at 250 days as compared with 400 days in Group I.
Ten animals died or were sacrificed before the 200th day of treatment. In these, the mammary glands showed marked development of the ducts and acini with the appearance of cysts and fibrosis in animals sacrificed after the 70th day. It is noteworthy that larger numbers of small cysts were present than in the animals of Group I. This finding may reflect the fact that the glands of animals which received stilbestrol by pellet underwent better development of acini with subsequent cystic dilatation.
Eight animals died or were sacrificed between the 200th and 250th days of treatment. In 6 of these metaplastic changes in the ducts were evident. The other 2 showed cystic disease only.
Of the 11 animals which survived from 270 to 420 days 8 showed carcinoma. In 7 of these 'the ducts only were involved while a single animal showed multiple growths, some of which contained adenocarcinoma. In one of the animals whose glands showed duct carcinoma only, one of the breasts contained areas which were regarded as intercanalicular adenofibroma. In 2 instances metastatic foci were found in regional lymph nodes. The three rats in which carcinoma was not found showed cysts, fibrosis, and metaplasia only. These rats were autopsied at from 350 to 420 days after the initial implantation and probably represent that group of animals whose glands are resistant to the development of carcinoma. In one instance a massive fibroma was present on the right forelimb. This growth involved the dorsal aspect of the upper limb, invading the extensor muscles, but not involving in any way the adjacent mammary gland.
The findings in this group are summarized in table 1. Group III. The animals in this group received 10 mg.-pellets of estrone (theelin) implanted under the skin of the back. As a rule 2 pellets were implanted initially with an additional implantation every 2 to 4 months. Most of the animals which lived more than 12 months received 6 pellets.
Seven rats were sacrificed between the 60th and 120th days of treatment. In each of these a marked cystic condition and an associated fibrosis were present.
Eight animals were sacrificed or died between the 130 and 200th days: In 2 of these, cysts and fibrosis only were present, 4 showed various degrees of metaplasia as well, and 2, both sacrificed at 150 days, had glands which contained carcinomas. In one of these the condition was early duct cancer, while in the second a massive undifferentiated adenocarcinoma (simplex) was present in one anterior gland. This growth had been noted for the first time less than three weeks before the animal was sacrificed and it had grown very rapidly, weighing 54 grams at autopsy. Metastases were present in the axillary and mediastinal lymph nodes.
Eleven animals died or were sacrificed between the 200th and 300th days. In 3 instances cysts and fibrosis only were found, 4 animals showed metaplastic changes in addition, and 4 showed early carcinoma. In one of these, the ducts and acini were involved, while duct cancer only was present in the remaining 3. No metastases were found.
The remaining 32 animals in this group continued on treatment for periods ranging from 300 to 500 days. In 4 instances, including 2 animals which lived to the 500th day, cysts and fibrosis only were present. Three animals, all living approximately 400 days, showed metaplasia as well as cysts and fibrosis.
In 5 animals early carcinoma was found. The glands of 2 of these showed involvement of both acini and ducts while in 3 duct carcinoma only was present. No metastases were found.
Twenty animals showed tumors that were regarded as advanced carcinoma. In 4 of these duct cancer was present, 2 showing metastases to lymph nodes, and 1 metastases to lymph nodes and lungs. In 5 animals the tumors were diagnosed as adenocarcinoma with metastases to lymph nodes in 3, and to both lymph nodes and lungs in 2 instances. Eight animals showed multiple tumors some of which, in each rat, were duct carcinoma and others adenocarcinoma. In 4 of these metatastic foci were found in regional lymph nodes, in 3 both lungs and lymph nodes showed metastases, and 1 animal appeared to be free from secondary growths. Two rats had tumors which were regarded as carcinoma simplex. As in the other instances where this type of cancer was seen the tumors grew very rapidly. In each case extensive metastases were seen in the regional lymph 224 nodes. A single animal showed duct carcinoma with extensive intraductal papillomatous growths and metastases to regional lymph nodes.
The results of observations on animals of Group III are summarized in table 1. It may be said that carcinoma appears to have developed more rapidly in the animals of this 'group than in those which received diethylstilbestrol. Cysts and fibrosis occurred as early as the 60th day, metaplasia by the 130th day, and carcinoma by the 150th day of treatment. The latter figure represents extreme instances, but it seems likely that in most of the animals which developed cancer the growths appeared before the 250th day. While duct carcinoma was the dominant type seen in animals treated with stilbestrol, adenocarcinoma was at least as common in animals which received pellets of estrone.
Discussion
Simplicity was regarded as desirable in the classification of the various cancers seen in this study. Thus, growths which appeared to involve ducts only and which usually were well circumscribed were diagnosed as duct carcinoma and were subdivided only into early (Fig. 2) and advanced (Fig. 3) stages on the basis of the number and the size of the intraductal growths. All instances in which the process appeared to involve terminal tubules and acini and in which the tumor maintained some measure of a lobular pattern have been classified as lobular or adenocarcinoma (Figs. 4  and 8 ). Some of these have shown a greater degree of infiltration than have others and on some bases of classification they would have been graded accordingly. Finally, those cancers in which the entire lo;bular pattern was destroyed and in which the cells were small, highly anaplastic, and tightly packed were regarded as carcinoma simplex or undifferentiated carcinoma (Fig. 5) . The metastatic growths have tended to follow the pattern seen in the primary tumor (Figs. 6 and 7) .
Although certain differences appeared in the rate of tumor formation in the several groups, the fundamental process appears to have been similar throughout. In all likelihood such differences as existed can probably be accounted for on the basis of variations in the, effective levels of estrogen. Thus, pellets of diethylstilbestrol or of estrone produced a more rapid sequence of mammary changes 225 than did daily injections of diethylstilbestrol, because effective levels of estrogen were maintained in a more constant fashion. The further acceleration seen in animals with pellets of estrone as compared to those with pellets of diethylstilbestrol may not be significant, since the number of animals in the latter series was relatively small. Furthermore, Geschickter and Byrnes8 observed no such difference in their more extensive examination of various estrogens. However, the more frequent occurrence of adenocarcinoma in animals which received pellets of estrone would indicate that estrone may have had a more marked effect than diethylstilbestrol on the acini.
In general, the observations which have been made in this study on animals derived from the Long-Evans hooded strain confirm the findings of Geschickter and Byrnes,8 who used a strain of albino rats. It should be noted that Noble, McEuen and Collip'" reported studies on black hooded rats of unknown genetic background in which they observed the occurrence of mammary tumors following the implantation of pellets of estrone. Although they were unwilling to classify these tumors as cancer, some of their illustrations indicate that certain of their rats, at least, had developed duct carcinoma. The differences between the observations reported here and those of Geschickter and Byrnes may be due, in part at least, to variations in responses shown by different strains of animals. Thus, the whole process seems to have been more rapid in their rats and in some cases they reported carcinoma at very early stages of treatment (21 to 90 days). Nothing approaching this rapidity was observed in our animals where it seems likely that the entire sequence of hyperplasia, cystic dilatation, fibrosis, and metaplasia preceded the appearance of anaplasia and cancer in each instance.
The more frequent occurrence of metastases of carcinoma simplex and of adenocarcinoma, both of which showed more marked tendencies toward infiltration than any of the duct carcinomas, was not surprising (see table 2 ). The very rapid growth shown by tumors which proved to be carcinoma simplex was remarkable. Even in those tumors which were studied within three weeks after they were first noted the complete lack of organization of the-parenchyma was striking. The small, tightly packed, highly anaplastic epithelial cells and the relative scarcity of well-defined stromal elements gave the superficial appearance of a sarcoma.
It is of interest to note the co-existence of mammary neoplasia and chromophobic adenomas of the hypophysis. This was true in every instance except for the animals of Group I in which the injections were discontinued. Although the observations on this latter series indicate that the altered endocrine relations which attend such tumors probably are not responsible for the full realization of neoplasia in the breast, they throw no light upon the factors responsible for the early stages of the process. The observations on this group of animals do indicate that continued treatment with estrogen is not essential for the complete development of carcinoma. In three of the animals biopsies taken at the time treatment was suspended showed early duct carcinoma. These tumors continued to develop during the subsequent period when no injections were given. In others, which went on to develop cancers, no tumors were detected at the cessation of treatment, although it cannot be asserted that the final stages of the process were not established. In this regard one is reminded of Cori's studies,2 in which the time of castration in cancersusceptible mice played a governing role in the occurrence of mammary carcinoma. If the various groups are examined for the incidence of cancer and those animals which survived treatment for at least 300 days or which developed cancer before that time are assembled it is seen that in Group I 29 of 54 animals (54 per cent) showed mammary carcinoma. In Group II 8 of 11 animals (73 per cent) and in Group III 31 of 38 animals (82 per cent) developed cancer. For all groups the figures are 68 of 103 animals (66 per cent). Although some of those rats which were negative when autopsied might have developed cancer if they had been able to continue on treatment, it is likely that most of them were resistant to the final stages of the neoplastic process.
Although no distinction has been made between the sexes in the account of these observations it may be noted that in the development of mammary carcinoma no significant difference could be detected between males and females, none of which was gonadectomized.
Summary
The administration of estrogenic substances by injection or by implantation of pellets in rats induced the appearance of mammary carcinoma in 68 of 103 animals which survived treatment long enough to permit the development of cancer (at least 300 days). It seems probable that some animals are resistant to the final stages of the neoplastic process which leads to the development of mammary carcinoma.
The various cases were distributed through several types of carcinoma. Duct carcnoma, 42 rats; adenocarcinoma, 8 rats; mixed duct and adenocarcinoma, 13 rats; carcinoma simplex, 5 rats. Metastases to lymph nodes or to lymph nodes and lungs were observed in 33 animals.
